Envestnet Asset Management
BLRX

Envestnet Asset Management’s BioLineRX BLRX Stock Holding History

Envestnet Asset Management’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,980
Closed -$128K – 4309
2024
Q3 		$128K Buy
5,980
+634
+12% +$17.4K ﹤0.01% 4097
2024
Q2 		$122K Buy
5,346
+3,986
+293% +$107K ﹤0.01% 4029
2024
Q1 		$60.9K Buy
1,360
+194
+17% +$9.73K ﹤0.01% 4098
2023
Q4 		$73.2K Sell
1,166
-287
-20% -$17.8K ﹤0.01% 3967
2023
Q3 		$106K Sell
1,453
-258
-15% -$17.3K ﹤0.01% 3867
2023
Q2 		$109K Sell
1,711
-762
-31% -$42.2K ﹤0.01% 3824
2023
Q1 		$87.7K Buy
+2,473
New +$65K ﹤0.01% 3809
2022
Q4 		– Sell
-746
Closed -$28K – 3954
2022
Q3 		$28K Sell
746
-538
-42% -$30.7K ﹤0.01% 3856
2022
Q2 		$66K Sell
1,284
-445
-26% -$24.7K ﹤0.01% 3793
2022
Q1 		$118K Sell
1,729
-1,327
-43% -$92.4K ﹤0.01% 3782
2021
Q4 		$249K Buy
3,056
+1,983
+185% +$207K ﹤0.01% 3522
2021
Q3 		$118K Buy
+1,073
New +$127K ﹤0.01% 3576

Other funds holding BLRX

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
OGF
Orin Green Financial San Diego, California $271M AUM 20.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Envestnet Asset Management's BLRX Position: Q4 2024 in Review

Envestnet Asset Management sold out of BioLineRX (BLRX) in Q4 2024, closing a stake of 5,980 shares — an estimated $128K sold.

Envestnet Asset Management first reported a position in BLRX in Q3 2021 and held it in 12 quarters. The position peaked at $249K in Q4 2021. 31 funds tracked by Wall St. Rank hold BLRX as of Q4 2024.

  • Envestnet Asset Management reported no remaining BioLineRX position as of Q4 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 5,980 BioLineRX shares in Q4 2024, an estimated $128K.
  • Envestnet Asset Management first reported a position in BioLineRX in Q3 2021 and held it in 12 quarters.
  • Envestnet Asset Management's BioLineRX position peaked at $249K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q4 2024.

Based on Envestnet Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.